COMMUNIQUÉS West-GlobeNewswire

HealthEC CIO Sita Kapoor Elected to Population Health Alliance Board of Directors

06/09/2019 - 15:30

Kapoor cited for her healthcare industry leadership and informatics expertise EDISON, N.J., Sept. 06, 2019 (GLOBE NEWSWIRE) -- HealthEC, LLC , a 2019 Best in KLAS provider of Population Health Management solutions, [...]

MEDIA ALERT: Organogenesis Holdings Inc. (Nasdaq: ORGO) to Ring the Nasdaq Stock Market Closing Bell

06/09/2019 - 15:00

NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- What: Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Gary S [...]

DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019

06/09/2019 - 15:00

MINNEAPOLIS, Sept. 06, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that management will attend the Lake Street Capital Markets 3 rd Annual Best Ideas Growth (BIG3) Conference on [...]

Demant A/S - press release: Update on IT infrastructure incident

06/09/2019 - 14:49

6 September 2019 Demant Group experienced a critical incident on our internal IT infrastructure on 3 September 2019. The Group’s IT infrastructure was hit by cyber-crime. Our quick response to the issue by shutting down [...]

Wave Life Sciences to Host Analyst and Investor Research Day on October 7, 2019

06/09/2019 - 14:30

Wave leadership to present updates on multiple preclinical programs and discuss advances in PRISM™ platform CAMBRIDGE, Mass., Sept. 06, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage [...]

Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments

06/09/2019 - 14:30

NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled “Gene Therapy Treatments Offer Hope for Cancer Patients [...]

Eve & Co Announces Third German Supply Agreement for Immediate Release

06/09/2019 - 14:24

TORONTO, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that its wholly-owned subsidiary Natural MedCo Ltd. has entered [...]

Organogenesis Announces Annual College Scholarship Award Winner

06/09/2019 - 14:00

Baylah Mazonson, 2019 Regenerative Medicine Scholarship Recipient, Will Attend Boston University This Fall CANTON, Mass., Sept. 06, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading [...]

Capricor Therapeutics to Present at Upcoming Conferences

06/09/2019 - 13:30

LOS ANGELES, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of [...]

BIOLIFE4D Launches Second Regulation A+ (Mini-IPO) Offering Due to Popular Demand

06/09/2019 - 13:30

Company surpassed $2M in accepted investments during highly successful first equity crowdfunding event; expects to make significant scientific announcement in the near future CHICAGO, Sept. 06, 2019 (GLOBE NEWSWIRE) -- [...]

Agile Therapeutics to Present at Upcoming Investor Conferences

06/09/2019 - 13:30

PRINCETON, N.J., Sept. 06, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that its Chairman and Chief Executive Officer, Al Altomari, will present at two [...]

BeyondSpring to Present at the H.C. Wainwright 21st Annual Global Investment Conference

06/09/2019 - 13:00

NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, announced [...]

Nabriva Therapeutics Earns $5 Million Milestone Payment under its License Agreement with Sinovant Sciences

06/09/2019 - 13:00

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Sept. 06, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti- [...]

Novavax to Present at the H.C. Wainwright 21st Annual Global Investment Conference

06/09/2019 - 13:00

GAITHERSBURG, Md., Sept. 06, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Stanley C [...]

Algernon Announces Pricing of Prospectus Offering

06/09/2019 - 13:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (“ Algernon ” or “ Company [...]

Opthea Presents Positive Data from OPT-302 Phase 2b Wet AMD Trial at EURETINA Congress

06/09/2019 - 11:30

MELBOURNE, Australia, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical biopharmaceutical company developing novel biologic therapies for eye diseases, announced today that new clinical data from [...]

Myovant Sciences’ Founding Shareholder Roivant Sciences, and Sumitomo Dainippon Pharma Enter into a Memorandum of Understanding to Create a Broad Strategic Alliance

06/09/2019 - 09:01

Roivant’s ownership interest in Myovant Sciences (approximately 46% of shares issued and outstanding) to be fully assumed by a new entity, Sumitomo Dainippon-Roivant Alliance, which will be wholly owned by Sumitomo [...]

BrainStorm Cell Therapeutics to Present Late Breaking News ePoster at the 35th ECTRIMS Congress

06/09/2019 - 07:50

NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. ( NASDAQ: BCLI ), a leader in the development of innovative autologous cellular therapies for highly debilitating neurodegenerative diseases [...]

European Commission approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of people with extensive-stage small cell lung cancer

06/09/2019 - 07:03

Tecentriq in combination with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy approved by the European Medicines Agency for the initial treatment of extensive-stage small cell lung [...]